Pot stocks fall, DEA eyes mid-Jan for cannabis rescheduling hearing

Canopy Growth

02/12/2024 20:29

(Updates)
    ** Shares of cannabis firms fall after U.S. Drug Enforcement
Administration's (DEA) preliminary hearing on marijuana
rescheduling proposal begins
    ** Toronto-listed shares of Canopy Growth  WEED.TO  dips
~3.8%, Trulieve Cannabis  TRUL.CD  falls 1.9%, 
        ** Canadian shares of Tilray Brands  TLRY.O  were down
1.6%
  
        ** John Mulrooney, presiding judge at the hearing, says
next set of hearings expected to be in mid-January 2025
  
    ** Despite marijuana being legal in dozens of U.S. states,
federal law categorizes it as a schedule I drug and prohibits
most conventional U.S. banks from doing business with cannabis
firms

 (Reporting by Seher Dareen and Pooja Menon in Bengaluru)
 ((Pooja.Menon@thomsonreuters.com;))